ATE119543T1 - Produktion von proteinen in aktiver form. - Google Patents

Produktion von proteinen in aktiver form.

Info

Publication number
ATE119543T1
ATE119543T1 AT88303594T AT88303594T ATE119543T1 AT E119543 T1 ATE119543 T1 AT E119543T1 AT 88303594 T AT88303594 T AT 88303594T AT 88303594 T AT88303594 T AT 88303594T AT E119543 T1 ATE119543 T1 AT E119543T1
Authority
AT
Austria
Prior art keywords
protein
cationic exchange
proteins
active form
production
Prior art date
Application number
AT88303594T
Other languages
English (en)
Inventor
Malcolm Roy Brandon
Joseph John Patroni
Original Assignee
Southern Cross Biotech Pty Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Southern Cross Biotech Pty Ltd filed Critical Southern Cross Biotech Pty Ltd
Application granted granted Critical
Publication of ATE119543T1 publication Critical patent/ATE119543T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/107—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides
    • C07K1/113—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides without change of the primary structure
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/61—Growth hormone [GH], i.e. somatotropin

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Endocrinology (AREA)
  • Zoology (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Toxicology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Analytical Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Biomedical Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
AT88303594T 1987-04-21 1988-04-21 Produktion von proteinen in aktiver form. ATE119543T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
AUPI150887 1987-04-21

Publications (1)

Publication Number Publication Date
ATE119543T1 true ATE119543T1 (de) 1995-03-15

Family

ID=3772123

Family Applications (1)

Application Number Title Priority Date Filing Date
AT88303594T ATE119543T1 (de) 1987-04-21 1988-04-21 Produktion von proteinen in aktiver form.

Country Status (11)

Country Link
US (1) US5008377A (de)
EP (1) EP0288280B1 (de)
JP (1) JPS646292A (de)
KR (1) KR880012753A (de)
AT (1) ATE119543T1 (de)
CA (1) CA1305285C (de)
DE (1) DE3853224T2 (de)
ES (1) ES2068827T3 (de)
MY (1) MY103362A (de)
NZ (1) NZ224295A (de)
ZA (1) ZA882774B (de)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1305285C (en) * 1987-04-21 1992-07-14 Malcolm Roy Brandon Production of proteins in active forms
EP0529086B1 (de) * 1991-02-26 1999-05-19 Ajinomoto Co., Inc. Verfahren zur reinigung von menschlichem bcdf
US6031075A (en) * 1996-02-05 2000-02-29 Children's Hospital Medical Center Mature alveolar SP-B and a process for producing the same
US20030190307A1 (en) 1996-12-24 2003-10-09 Biogen, Inc. Stable liquid interferon formulations
CA2338665C (en) 1998-08-06 2011-01-18 Mountain View Pharmaceuticals, Inc. Peg-urate oxidase conjugates and use thereof
US8188224B2 (en) 2005-04-11 2012-05-29 Savient Pharmaceuticals, Inc. Variant forms of urate oxidase and use thereof
US7811800B2 (en) 2005-04-11 2010-10-12 Savient Pharmaceuticals, Inc. Variant form of urate oxidase and use thereof
US8148123B2 (en) 2005-04-11 2012-04-03 Savient Pharmaceuticals, Inc. Methods for lowering elevated uric acid levels using intravenous injections of PEG-uricase
WO2008051178A2 (en) 2006-04-12 2008-05-02 Savient Pharmaceuticals, Inc. Purification of proteins with cationic surfactant
US20080159976A1 (en) * 2005-04-11 2008-07-03 Jacob Hartman Methods for lowering elevated uric acid levels using intravenous injections of PEG-uricase
JP2008545665A (ja) * 2005-05-23 2008-12-18 ユニベルシテ ドゥ ジュネーブ 高体温による処置のための注入可能な超常磁性ナノ粒子および高体温インプラントを形成するための使用
EP4635567A3 (de) 2009-06-25 2025-12-03 Horizon Therapeutics USA, Inc. Verfahren und kits zur prävention des infusionsreaktionsrisikos und antikörpervermittelter reaktionsverlust durch überwachung von serumharnsäure während der pegylierten harnasetherapie
US20200237881A1 (en) 2019-01-30 2020-07-30 Horizon Pharma Rheumatology Llc Reducing immunogenicity to pegloticase
CN110234340A (zh) 2016-11-11 2019-09-13 好利恩风湿病制药有限责任公司 泼尼松和尿酸酶分子的组合疗法及其用途
IL281804B2 (en) * 2018-09-25 2025-09-01 Absci Llc Protein purification methods
US12121566B2 (en) 2019-01-30 2024-10-22 Horizon Therapeutics Usa, Inc. Methods for treating gout
US12269875B2 (en) 2023-08-03 2025-04-08 Jeff R. Peterson Gout flare prevention methods using IL-1BETA blockers

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2829089A1 (de) * 1977-07-13 1979-02-01 Sandoz Ag Subunit-vakzine
GB8508340D0 (en) * 1985-03-29 1985-05-09 Creighton T E Production of protein
US4748234A (en) * 1985-06-26 1988-05-31 Cetus Corporation Process for recovering refractile bodies containing heterologous proteins from microbial hosts
US4766224A (en) * 1985-08-19 1988-08-23 International Minerals & Chemical Corp. Purification and activation of proteins from insoluble inclusion bodies
US4677196A (en) * 1985-09-06 1987-06-30 International Minerals & Chemical Corp. Purification and activation of proteins from insoluble inclusion bodies
AU597924B2 (en) * 1985-12-11 1990-06-14 Natinco Nv Solubilization of protein aggregates
CA1305285C (en) * 1987-04-21 1992-07-14 Malcolm Roy Brandon Production of proteins in active forms

Also Published As

Publication number Publication date
DE3853224D1 (de) 1995-04-13
MY103362A (en) 1993-06-30
NZ224295A (en) 1990-06-26
DE3853224T2 (de) 1995-06-29
EP0288280B1 (de) 1995-03-08
EP0288280A2 (de) 1988-10-26
CA1305285C (en) 1992-07-14
ES2068827T3 (es) 1995-05-01
KR880012753A (ko) 1988-11-29
US5008377A (en) 1991-04-16
ZA882774B (en) 1988-10-20
EP0288280A3 (en) 1990-04-11
JPS646292A (en) 1989-01-10

Similar Documents

Publication Publication Date Title
DE3853224D1 (de) Produktion von Proteinen in aktiver Form.
DE3382837T2 (de) Herstellung von funktionellen, menschlichen Urokinaseproteinen
DK247084A (da) 7-amino-1-cyclopropyl-6,8-difluor-1,4-dihydro-4-oxo-3-quinolincarboxylsyrer, fremgangsmaader til deres fremstilling samt antibakterielle midler indeholdende disse
ATE73138T1 (de) Reinigung und aktivierung von proteinen aus unloeslichen einschlusskoerpern.
IL79972A0 (en) Protein recovery
DK0383234T3 (da) Pasteuriseret, renset von Willebrand-faktor-koncentrat og fremgangsmåde til dets fremstilling
ATA192895A (de) Herstellung von proteinen aus pro-proteinen durch fusionsproteine abgeleitet von furin oder furinanalogen
ATE124703T1 (de) Verfahren zur trennung von proteinen.
DE3882078D1 (de) Amperometrische methode zur titration von nadh (1,4-dihydronicotinamid-adenine-dinucleotide) in loesung.
EP0239311A3 (de) Wechselseitige Trennung von Proteinen
FI863626A7 (fi) DNA-sekvenssejä, yhdistelmä-DNA -molekyylejä ja menetelmiä ihmisen lip okortiinin kaltaisia polypeptidejä.
DK38889A (da) Onkogen-indkodet polypeptid med vaekstfaktoraktivitet
DE3788170D1 (de) Methode zur Reinigung und Isolierung von zwei ionischen Formen von Somatomedin.
RU96115481A (ru) Способ лечения деформирующего остеоартроза крупных суставов
ES2078229T3 (es) Procedimiento para la preparacion de un polipeptido similar a la motilina y su expresion.
FI863145A7 (fi) Kloonausvehikkeli suuren DNA-fragmentin kloonaamiseksi ja 987P fimbr iaaliproteiinia sisältävä rokote.
GR3003950T3 (de)
DE3677851D1 (de) Verfahren zur steigerung der produktion von rekombinantem protein in hefearten der gattung saccharomyces.
FI934079L (fi) Menetelmä fuusioproteiinin valmistamiseksi
ATE93546T1 (de) Ergaenzungstestverfahren von proteine bindenden enzymen.
DE3784891D1 (de) Verfahren zur isolierung von saeurestabilen, biologisch aktiven proteinen.
FI862140A7 (fi) Menetelmä aktiivihiilen talteenottamiseksi.
BR8205912A (pt) Processo de separacao das proteinas contidas nas turfas hidricas, (sapropelitos).
ATE104700T1 (de) Neue thrombolytische proteine.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
EEIH Change in the person of patent owner
REN Ceased due to non-payment of the annual fee